Imedex, LLC is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.be.
The 11th World Congress on Gastrointestinal Cancer is designated for a maximum of 20 hours of European external CME credits. Each medical specialist should claim only those hours of credit that she/he actually spent in the educational activity.
EACCME credits are recognized by the American Medical Association toward the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA Category 1 credit, contact the AMA.
Who Should Attend
This Congress is specifically designed for practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract. Other healthcare professionals may also find this program beneficial. No specific knowledge other than a basic understanding of cancer and the digestive system is necessary to participate in this course.
- Identify current controversies in the management of patients with gastric or oesophageal cancers
- Discuss contemporary treatment options for patients with gastric or oesophageal cancers
- Comment on available treatment options for rare gastrointestinal and neuroendocrine tumors
- Recognize the epidemiology and pathogenesis of hepatocellular carcinoma
Discuss management of patients with cancer of the liver
- Understand adjuvant and neoadjuvant treatment options for patients with locally advanced and metastatic cancer of the pancreas
- Select the most appropriate detection, screening and chemoprevention methods for colorectal cancer
- Generalize the use of molecular markers for screening and prognosis of colorectal cancer and gastric cancer
- Select the most appropriate adjuvant and neoadjuvant treatments for colorectal cancer patients
- Comment on new agents in the treatment of colorectal cancer and the latest clinical trials results
- Identify treatment strategies for rectal cancer
- Distinguish appropriate surgical techniques for the treatment of gastrointestinal cancers
This Congress is developed and managed by Imedex.
4325 Alexander Drive
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
©2008 Imedex®, LLC. All rights reserved. Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.